Company Filing History:
9 out of 234 
2 out of 106 
1 out of 10 
Years Active: 2003-2010
Title: The Innovative Contributions of Hong Liu
Introduction
Hong Liu is a prominent inventor based in Glen Mills, PA (US), known for her significant contributions to the field of pharmaceuticals. With a total of 13 patents to her name, she has made remarkable strides in developing novel compounds aimed at treating neurological disorders.
Latest Patents
One of her latest patents focuses on "Substituted lactams as inhibitors of Aβ protein production." This invention relates to novel lactams of Formula (I), which possess drug and bio-affecting properties. These compounds inhibit the processing of amyloid precursor protein and specifically target the production of Aβ-peptide. By doing so, they act to prevent the formation of neurological deposits of amyloid protein. This invention is particularly relevant for the treatment of neurological disorders associated with β-amyloid production, such as Alzheimer's disease and Down's Syndrome.
Career Highlights
Throughout her career, Hong Liu has worked with notable companies, including Bristol-Myers Squibb Pharma Company and DuPont Pharmaceuticals Company. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.
Collaborations
Hong Liu has collaborated with esteemed colleagues, including Richard Eric Olson and Michael G Yang. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Hong Liu's innovative work and dedication to developing treatments for neurological disorders highlight her importance in the field of pharmaceuticals. Her contributions continue to pave the way for advancements that can significantly impact patient care and treatment options.